Invictus RG’s Abiomed Inc ABMD Stock Holding History

Invictus RG’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,217	Closed	-$354K	–	325
2018 Q1	$354K	Buy	+1,217	New	+$308K	0.24%	109
2017 Q1	–	Sell	-106	Closed	-$12K	–	867
2016 Q4	$12K	Buy	+106	New	+$12.3K	0.01%	599

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invictus RG's ABMD Position: Q2 2018 in Review

Invictus RG sold out of Abiomed Inc (ABMD) in Q2 2018, closing a stake of 1,217 shares — an estimated $354K sold.

Invictus RG first reported a position in ABMD in Q4 2016 and held it in 2 quarters. The position peaked at $354K in Q1 2018. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

Invictus RG reported no remaining Abiomed Inc position as of Q2 2018 after selling out during the quarter.
Invictus RG sold 1,217 Abiomed Inc shares in Q2 2018, an estimated $354K.
Invictus RG first reported a position in Abiomed Inc in Q4 2016 and held it in 2 quarters.
Invictus RG's Abiomed Inc position peaked at $354K in Q1 2018.
527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Invictus RG's 13F filing for Q2 2018, filed 13 Aug 2018.